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In the 2001 edition of the textbook Heart Disease (1)
Brugada syndrome is defined as a “distinct form of idio-
pathic ventricular fibrillation (VF) in which patients have
right bundle branch block (RBBB) and ST elevation in the
anterior precordial leads without evidence of structural heart
disease.” Although patients with such characteristics were
described before the Brugada brothers reported their find-
ings (2), the eponym “Brugada syndrome” is a deserved
tribute to these investigators, who were the first to define
this syndrome as a distinct functional cardiac disorder (3).
The three components of the syndrome are: 1) syncope
and sudden cardiac death (SCD); 2) absence of structural
heart disease, QT prolongation, and metabolic or pharma-
cologic factors for triggering cardiac arrest; and 3) complete
or incomplete RBBB with elevation of the ST segment or of
the J point in the leads V1 to V2 and V3, which will be
referred to as Brugada electrocardiogram (ECG) pattern.
See page 771
Additional findings that support the diagnosis but are not
universally present include 1) prevalence in men; 2) familial
incidence; 3) molecular defect in the structure of the cardiac
sarcolemmal sodium channel gene, SCN5A, resulting in the
malfunction of this channel (channelopathy); 4) character-
istic response to pharmacologic challenge with class IA or
IC sodium channel-blocking drugs, which exaggerate the
existing ST-segment elevation in the right precordial leads
and unmask the ST-segment elevation when it ceases to be
present; and 5) induction of VF, or sustained ventricular
tachycardia during programmed electrical stimulation
(PES). The criteria for diagnosing Brugada syndrome can
be applied to some victims of the unexplained “death
syndrome” in young male Southeast Asians (4) and to some
patients with idiopathic VF (5). Brugada syndrome, how-
ever, should not be confused with arrhythmogenic right
ventricular cardiomyopathy (ARVC), although the two
conditions share the characteristic ECG pattern, and the
propensity for SCD.
OTHER CAUSES OF BRUGADA ECG PATTERN
The Brugada ECG pattern resembles RBBB with ST-
segment elevation caused by anteroseptal ischemia or myo-
cardial infarction (MI), right ventricular ischemia or MI,
pulmonary embolism, hyperkalemia, and by cardiac trans-
plantation. In patients with RBBB, ST-segment elevation
can be simulated by a retrograde P-wave during atrioven-
tricular junctional rhythm, or by a Ta-wave in the presence
of a deeply negative P-wave with a short PR interval.
Gussak et al. (6) listed 18 conditions that can be associ-
ated with ST-segment elevation in the right precordial
leads. None of these conditions, with the possible exception
of the overdose with sodium channel-blocking heterocyclic
antidepressant drugs, are likely to be suspected of being
related to Brugada syndrome. In some cases, however, the
ST-segment elevation in the presence of RBBB remains
unexplained. In my collection of 41 ECGs with the Brugada
ECG pattern in patients without history of aborted SCD,
12 subjects had unexplained coved ST-segment elevation in
the right precordial leads.
PROBLEMS WITH DOCUMENTING THE DIAGNOSIS OF
BRUGADA SYNDROME
The problems that may complicate proper recognition of
the Brugada syndrome fall into the following three catego-
ries: 1) ruling out structural heart disease that may cause
SCD in subjects with Brugada ECG pattern; 2) definition
of Brugada ECG pattern; and 3) clinical significance of
unexplained asymptomatic Brugada ECG pattern.
Ruling out structural heart disease. Diagnosis of Brugada
syndrome requires ruling out conditions known to cause
SCD unless such conditions are acquired after the estab-
lishment of the Brugada syndrome.
A complete workup of a symptomatic patient with
Brugada ECG pattern may require, in addition to the
routine history, physical examination and ECG, a trans-
thoracic or transesophageal echocardiogram, coronary an-
giogram, stress test, magnetic resonance imaging and, in
some cases, myocardial biopsy. Facilities to perform such
studies are not universally available. Even if the facilities are
available such extensive workup cannot be justified in
asymptomatic patients. Other tests are not necessarily help-
ful. Studies by Priori et al. (7) in 30 symptomatic and 30
asymptomatic patients with the Brugada ECG pattern
showed that PES identified only a fraction of individuals at
risk, and that sodium channel blockade failed to unmask
most silent gene carriers. In the Priori et al. (7) study,
prevalence of mutations of the cardiac sodium channel was
15%, demonstrating genetic heterogeneity of the syndrome.
Definition of Brugada ECG pattern. The QRS pattern of
patients with Brugada syndrome may show complete
RBBB, incomplete RBBB, or “focal” RBBB in which the
QRS complex with the terminal R9 deflection in the right
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precordial lead is longer than in the other leads, which lack
the expected terminal S-wave. In some cases the elevated
J-wave point is followed by a downsloping ST segment
ending in a negative deflection (6). In the studies that
mention the qualifying amplitude of ST-segment elevation,
the usual value is $1.0 mm (0.1 mV). The accuracy of the
measurements depends on the selection of the reference
point on the baseline and of the J point. I find it difficult to
discern the difference between ST-segment elevation of
0.9 mm (no Brugada ECG pattern) and 1.0-mm elevation
(defining the Brugada pattern) without the magnification of
the tracing, a procedure that is rarely, if ever, mentioned in
the Methods section. More importantly, one needs to
consider that, independent of other factors, the magnitude
of the ST-segment elevation is influenced by the absolute
amplitude of the ECG complex. Thus, a ST-segment
elevation of 0.1 to 0.2 mV may be physiologic in a QRST
complex of high amplitude, and pathologic in a QRST
complex of low amplitude.
The ST segment can be concave (saddle-back), convex
(coved), or straight (i.e., of triangular shape) (6). These
patterns can be present permanently or intermittently. The
saddle-back pattern is more often encountered as a normal
variant of early repolarization and in other conditions
unrelated to Brugada syndrome, but it cannot be dismissed
as harmless, because in the study by Atarashi et al. (8) the
pattern of RBBB with saddle-back ST-segment elevation
was present in 1 of 17 patients with VF and in 3 of 12
patients with syncope. These investigators have shown that
both the contour and the amplitude of ST-segment eleva-
tion can vary in the same patient during the follow-up. It is
also known that some subjects may have a saddle-back
pattern in one of the right precordial leads and a coved
pattern in the neighboring precordial lead. Gussak et al. (6)
concluded that the diagnosis of Brugada syndrome cannot
be made on the basis of the ECG alone. The importance of
this statement should not be underestimated.
Clinical significance of unexplained asymptomatic Bru-
gada ECG pattern. PREVALENCE OF THE SYNDROME IN
THE SURVEYS OF BRUGADAS. In 1992, Brugada and Bru-
gada described the syndrome in six men and two women (3).
In 1998, Brugada et al. (9) presented data on 63 patients
recruited in 33 centers around the world. In a report
published in 2001 (10) these investigators described 239
patients with a “Brugada ECG.” This cohort included an
unspecified number of asymptomatic patients. The growing
numbers reflect the increasing recognition of the syndrome,
which might have been aided by the introduction of a
World Wide Web home page of the Brugada syndrome on
the internet in 1997 (6).
PREVALENCE OF BRUGADA SYNDROME AND BRUGADA ECG
PATTERN IN OTHER STUDIES. Atarashi et al. (8) found 63
patients with RBBB and ST-segment elevation during a
seven-month period of registration from 34 institutions in
Japan, but the number of screened ECGs was not specified.
In two other studies from Japan, the prevalence of Brugada
ECG (only the coved type with rSR9 pattern) was 0.07%
among 4,092 healthy adult patients (ref. 6 in ref. 11) and
0.21% among 3,300 patients undergoing routine checkup
(12).
In other studies, Hermida et al. (13) found 1 case among
1,000 apparently healthy subjects (0.1%), and Monroe and
Littman (14) found 52 cases of Brugada ECG pattern
among approximately 12,000 unselected noncardiac pa-
tients. In their study, saddle-back pattern was present in 50
cases and coved pattern was present in 2 cases.
An important addition to the above scanty data is the
study by Miyasaka et al. (11) published in this issue of the
Journal. The investigators examined prevalence of the Bru-
gada ECG pattern in 13,929 patients in whom ECG was
recorded during routine health examination in a middle-
sized Japanese city, Moriguchi, Osaka, in the year 1997. In
this city the health examination was offered to patients who
were older than 40 years or to younger patients suspected to
have a cardiac anomaly. A Brugada-type ECG was defined
as RBBB and ST-segment elevation .0.1 mV in the leads
V1 to V2 and V3. Of the two interpreters, one diagnosed the
pattern in 104 subjects and the other in 133 subjects. A
99.7% agreement between these two observers was reached
on 98 ECGs. As expected, the pattern was more prevalent
in men. The saddle-back type of ST-segment elevation was
present in 81 and the coved pattern in 37 patients. In those
with coved type, 17 patients had rsR9 pattern (considered by
the investigators as “typical”) and 20 had Rsr9 pattern. The
prevalence of all types was 0.7%; of the coved type was
0.26%, and of the coved rSR9 pattern was 0.12%. Among
male patients, the prevalence of all types was 2.14%, and of
the coved rSR9 pattern it was 0.38%.
The large differences in the prevalence in the reported
studies are not surprising considering the lack of uniform
methodology to define the population in terms of gender, age
and presence or absence of heart disease, as well as the absence
of uniform criteria defining the Brugada ECG pattern.
Of the three studies in which only the coved type was
considered, the prevalence of this pattern was 0.016% in the
study by Monroe and Littman (14); 0.1% in the small
sample of Hermida et al. (13); and 0.26% in the cases
studied by Miyasaka et al. (11). The latter study (11)
provides the most useful assessment of the prevalence of the
Brugada ECG pattern because the investigators examined
the largest population group, and they reported their find-
ings separately for men and women as well as for the three
different types of Brugada ECG pattern.
It is not known, however, whether the screened cohort
was representative of the population in the city of Morigu-
chi, Osaka, because it included only volunteers who might
have been more concerned about their health status and an
unspecified number of subjects suspected to have cardiac
abnormalities. More carefully designed studies are needed to
assess the prevalence of Brugada-type ECG throughout the
world.
776 Surawicz JACC Vol. 38, No. 3, 2001
Editorial Comment September 2001:775–7
Follow-up of patients with Brugada-type ECG. Brugada
et al. (10) reported an 8% incidence of arrhythmic events
among asymptomatic patients with a Brugada-type ECG
during a three-year follow-up. In contrast, no cardiac events
occurred in asymptomatic patients followed for an average
of about one to three years by Atarashi et al. (8) (34
patients), Takenaka et al. (12) (11 patients) and Priori et al.
(7) (30 patients). In the Moriguchi, Osaka, population (11),
which was followed for an average of 2.6 years, one SCD
occurred among 98 subjects with the Brugada-type ECG in
a 56-year-old man with a saddle-back ST-segment eleva-
tion. Among 13,831 patients without the Brugada-type
ECG, 139 died during the same period. The difference in
mortality between the two groups was not significant.
According to Brugada et al. (10), the periods of observation
in the available studies are too short to draw meaningful
conclusions about the risk of serious arrhythmic events in
asymptomatic subjects with Brugada-type ECG.
It appears that Brugada syndrome represents a rare cause
of SCD in patients without structural heart disease. Chugh
et al. (15) identified 14 structurally normal hearts among
270 hearts of SCD victims. Brugada syndrome was sus-
pected in one patient of Southeast Asian origin who had no
ECG. Corrado et al. (16) reported that of nine young
victims of SCD with ST-segment elevation in the right
precordial leads, eight had ARVC, and one had no struc-
tural heart disease (i.e., the Brugada syndrome).
CONCLUSIONS
Although the Brugada-type ECG cannot be defined accu-
rately, most symptomatic patients with the manifest. Bru-
gada syndrome appear to have RBBB with a coved type
ST-segment elevation. The syndrome may be concealed
when the typical ECG pattern transiently disappears in
subjects with the manifest Brugada syndrome. The term
“asymptomatic Brugada syndrome” is an oxymoron, and it
should not be used in reference to asymptomatic subjects
with the Brugada-type ECG. These individuals may be
diagnosed as either carriers of the pattern or as having
suspected Brugada syndrome. At this time there are no
guidelines to gauge the level of suspicion as strong, inter-
mediate or weak, with the possible exception of young men
of Southeast Asian origin and patients who have a family
history of the syndrome. Further studies may disclose which
ECG patterns should be suspected of Brugada syndrome,
and which patterns can be safely dismissed as merely
simulating the Brugada syndrome. The unresolved prob-
lems related to the pathogenesis (17), the ECG character-
istics, the epidemiology, and the genetic features all require
further studies.
The available data suggest that the Brugada-type ECG is
much more prevalent than the manifest Brugada syndrome. Of
the several studies in which the patients with asymptomatic
Brugada-type ECG were followed prospectively, only one (10)
reported occurrence of symptomatic arrhythmias.
There are no established guidelines on how to handle the
asymptomatic patients with an unexplained Brugada-type
ECG. A concerned physician faces the dilemma of whether
to conceal the ECG findings from the patient or to inform
the asymptomatic patient about the presence of an “atypical”
ECG, which may or may not be of consequence. There is
not enough information compelling the physician to reveal
the increased risk of SCD to every patient with the Brugada
ECG pattern.
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